This protocol is judged by an institutional critique board, an impartial team that assessments any clinical trials involving people. If a review requires a Agenda I drug, when the board approves the protocol as moral, the researchers have to make an application for an investigational new drug (IND) number with the FDA.Some scientists and corporati